Back to STATE STREET CORP STATE STREET CORP

SGMTSGMT
Showing 8 of 12 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in SAGIMET BIOSCIENCES INC

Yes. State Street holds 1,995,092 shares of SGMT (Sagimet Biosciences), worth $15.4M, as of its Q2 2026 13F filing. It increased the position from 128,788 shares in Q1 2026. State Street has held SGMT in every 13F on record since Q3 2023, 12 quarterly filings.

Current Value

$15.4M

Current Shares

2M

Total Value Change

+$15.3M

Total Shares Change

+1.9M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2M
+1449.1%
$15.4M0.0%$7.73
45
2026-Q1
Increased
128,788
+9.7%
$672,9170.0%$5.62
18
2025-Q4
Increased
117,388
+6.3%
$694,9370.0%$5.85
18
2025-Q3
Increased
110,488
+10.7%
$757,9480.0%$6.92
19
2025-Q2
Unchanged
99,800
0.0%
$760,4760.0%$7.87
0
2025-Q1
Increased
99,800
+18.7%
$325,3480.0%$3.71
19
2024-Q4
Increased
84,100
+55.2%
$378,4500.0%$4.72
23
2024-Q3
Unchanged
54,200
0.0%
$150,1340.0%$2.82
0

Other major holders of SGMT: BlackRock, Inc., BALYASNY ASSET MANAGEMENT L.P., FMR LLC, Woodline Partners LP, VANGUARD CAPITAL MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used